Correlation Between C Rad and Enorama Pharma
Can any of the company-specific risk be diversified away by investing in both C Rad and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C Rad and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C Rad AB and Enorama Pharma AB, you can compare the effects of market volatilities on C Rad and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C Rad with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of C Rad and Enorama Pharma.
Diversification Opportunities for C Rad and Enorama Pharma
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CRAD-B and Enorama is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding C Rad AB and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and C Rad is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C Rad AB are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of C Rad i.e., C Rad and Enorama Pharma go up and down completely randomly.
Pair Corralation between C Rad and Enorama Pharma
Assuming the 90 days trading horizon C Rad AB is expected to under-perform the Enorama Pharma. But the stock apears to be less risky and, when comparing its historical volatility, C Rad AB is 2.39 times less risky than Enorama Pharma. The stock trades about -0.28 of its potential returns per unit of risk. The Enorama Pharma AB is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 394.00 in Enorama Pharma AB on August 26, 2024 and sell it today you would lose (17.00) from holding Enorama Pharma AB or give up 4.31% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
C Rad AB vs. Enorama Pharma AB
Performance |
Timeline |
C Rad AB |
Enorama Pharma AB |
C Rad and Enorama Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with C Rad and Enorama Pharma
The main advantage of trading using opposite C Rad and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C Rad position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.C Rad vs. CellaVision AB | C Rad vs. Biotage AB | C Rad vs. Boule Diagnostics AB | C Rad vs. RaySearch Laboratories AB |
Enorama Pharma vs. Stille AB | Enorama Pharma vs. Midsona AB | Enorama Pharma vs. C Rad AB | Enorama Pharma vs. Novotek AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets |